| Bioactivity | Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers[1]. |
| Name | Pulocimab |
| CAS | 2428381-49-9 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82(12):1333-1339. |